Wan Chang
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Chromatin Remodeling and Cancer
- Epigenetics and DNA Methylation
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Xiaowei Wu (12 shared papers)Zhihua Liu (12 shared papers)Pengfei Zhao (12 shared papers)Qingyu Luo (12 shared papers)Yabing Nan (9 shared papers)Dan Su (4 shared papers)Tong Shu (3 shared papers)Fang Ding (3 shared papers)
- Journals
- Cell Reports (3 papers)Cancer Research (2 papers)Cell Death and Differentiation (2 papers)Proceedings of the National Academy of Sciences (2 papers)Advanced Science (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wan Chang
12 papers receiving 457 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 98
- Molecular Biology 349
- Oncology 124
- Pathology and Forensic Medicine 57
- Immunology 39
Countries citing papers authored by Wan Chang
This map shows the geographic impact of Wan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Chang more than expected).
Fields of papers citing papers by Wan Chang
This network shows the impact of papers produced by Wan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Chang. The network helps show where Wan Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wan Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2021 | 63 | |
| 3 | 2019 | 59 | |
| 4 | 2020 | 44 | |
| 5 | 2019 | 39 | |
| 6 | 2018 | 37 | |
| 7 | 2022 | 32 | |
| 8 | 2022 | 30 | |
| 9 | 2020 | 28 | |
| 10 | 2022 | 23 | |
| 11 | 2023 | 20 | |
| 12 | 2024 | 16 |
About Wan Chang
Wan Chang is a scholar working on Cancer Research, Pathology and Forensic Medicine, Molecular Biology, Oncology and Cell Biology, having authored 12 papers that have together received 459 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer Mechanisms and Therapy (4 papers), Chromatin Remodeling and Cancer (4 papers), RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Histone Deacetylase Inhibitors Research (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Cancer Research (98 citations), Molecular Biology (349 citations), Oncology (124 citations), Pathology and Forensic Medicine (57 citations) and Immunology (39 citations). Wan Chang has collaborated with scholars based in China and United States. Frequent co-authors include Xiaowei Wu, Zhihua Liu, Pengfei Zhao, Qingyu Luo, Yabing Nan, Dan Su, Tong Shu, Fang Ding, Xiaolin Zhu and Bin Li. Their work appears in journals such as Cell Reports, Cancer Research, Cell Death and Differentiation, Proceedings of the National Academy of Sciences and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.